PIVOT-02: A phase 1/2, open-label, multicenter, dose escalation and dose expansion study of NKTR-214 and nivolumab in patients with select, locally advanced or metastatic solid tumor malignancies

被引：0

作者：

Diab, A. ^{[1
]}

Hurwitz, M. E. ^{[2
]}

Tannir, N. ^{[3
]}

Bernatchez, C. ^{[1
]}

Haymaker, C. ^{[1
]}

Bentebibel, S. E. ^{[1
]}

Curti, B. D. ^{[4
,5
]}

Wong, M. K. K. ^{[1
]}

Gergel, I. ^{[6
]}

Tagliaferri, M. ^{[7
]}

Zalevsky, J. ^{[8
]}

Hoch, U. ^{[9
]}

Aung, S. ^{[7
]}

Imperiale, M. ^{[7
]}

Cho, D. ^{[10
]}

Tykodi, S. S. ^{[11
,12
]}

Puzanov, I. ^{[13
]}

Kluger, H. ^{[14
]}

Hwu, P. ^{[1
]}

Sznol, M. ^{[15
]}

机构：

[1] MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX USA

[2] Yale Sch Med, Div Med Oncol, Dept Internal Med, New Haven, CT USA

[3] MD Anderson Canc Ctr, Genitourinary Med Oncol, Houston, TX USA

[4] Providence Canc Ctr, Dept Genitourinary Oncol Res, Portland, OR USA

[5] Earle A Chiles Res Inst, Portland, OR USA

[6] Nektar Therapeut, Dept Drug Dev, San Francisco, CA USA

[7] Nektar Therapeut, Dept Clin Dev, San Francisco, CA USA

[8] Nektar Therapeut, Dept Biol & Preclin Dev, San Francisco, CA USA

[9] Nektar Therapeut, Dept Clin Pharmacol, San Francisco, CA USA

[10] NYU Med Oncol Associates, Dept Med Oncol, New York, NY USA

[11] Univ Washington, Dept Med Oncol, Seattle, WA 98195 USA

[12] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

[13] Roswell Pk Canc Inst, Dept Med Oncol, Buffalo, NY 14263 USA

[14] Yale Breast Ctr, Dept Med Oncol, New Haven, CT USA

[15] Yale Univ, Sch Med Med Oncol, Dept Med Oncol, New Haven, CT USA

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1212TiP

引用

页数：1

共 50 条

[21] IL believe: A phase 1/2, open-label, dose escalation and dose expansion study of TransCon IL-2 ß/γ alone or in combination with pembrolizumab or standard-of-care chemotherapy in patients with locally advanced or metastatic solid tumors [J].

Starodub, Alexander ;

Gabrail, Nashat Y. ;

Zhang, Ying ;

Castro, Davis Y. Torrejon ;

Slavsky, Sibel ;

Singel, Stina Mui ;

Powderly, John D. .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)

[22] A phase I, open-label, multicenter, dose escalation and expansion study of HM97662 (EZH1/2 dual inhibitor) as a single agent in patients with advanced or metastatic solid tumors [J].

Keam, B. ;

Ahn, J-H. ;

Kim, K. ;

Hong, S-H. ;

Ganju, V. ;

Lim, L. E. ;

Kwatra, V. ;

Body, A. ;

Rhee, P. D. ;

Jung, S. ;

Yoon, J. ;

Baek, E. ;

Noh, Y. S. .

ANNALS OF ONCOLOGY, 2024, 35 :S532-S532

[23] Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial [J].

El-Khoueiry, Anthony B. ;

Sangro, Bruno ;

Yau, Thomas ;

Crocenzi, Todd S. ;

Kudo, Masatoshi ;

Hsu, Chiun ;

Kim, Tae-You ;

Choo, Su-Pin ;

Trojan, Jorg ;

Welling, Theodore H., III ;

Meyer, Tim ;

Kang, Yoon-Koo ;

Yeo, Winnie ;

Chopra, Akhil ;

Anderson, Jeffrey ;

dela Cruz, Christine ;

Lang, Lixin ;

Neely, Jaclyn ;

Tang, Hao ;

Dastani, Homa B. ;

Melero, Ignacio .

LANCET, 2017, 389 (10088) :2492-2502

[24] Vorolanib (CM082) in Chinese patients with advanced solid tumor: A phase 1, open-label, dose escalation study. [J].

Song, Yan ;

Wang, Jinwan ;

Zhou, Ai-Ping ;

Zhang, Wen ;

Liang, Chris ;

Yang, Lin .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

[25] transcendIT-101: A phase 1/2, open-label, dose escalation and dose expansion study of TransCon TLR7/8 Agonist alone or in combination with pembrolizumab in patients with locally advanced or metastatic solid tumors. [J].

Davar, Diwakar ;

Singel, Stina M. ;

Nyamuswa, Gil ;

Tuan-Anh Tran ;

Wu, Yang ;

Grewal, Jaspreet ;

Aghmesheh, Morteza ;

Spira, Alexander ;

Ganju, Vinod ;

Rand, Jamie ;

Frentzas, Sophia ;

Bajor, David ;

Gabrail, Nashat .

CANCER RESEARCH, 2022, 82 (12)

[26] A phase 1, open-label, dose escalation study of AMG 337 in Asian patients (pts) with advanced solid tumors [J].

Yasui, Hirofumi ;

Amore, Benny ;

Jiang, Yizhou ;

Murugappan, Swaminathan ;

Doi, Toshihiko .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

[27] PIVOT-10: A phase II study of bempegaldesleukin (NKTR-214) in combination with nivolumab (NIVO) in cisplatin (cis) ineligible patients with previously untreated locally advanced or metastatic urothelial cancer (mUC) [J].

Huddart, Robert A. ;

Siefker-Radtke, Arlene O. ;

Balar, Arjun Vasant ;

Bilen, Mehmet Asim ;

Powles, Thomas ;

Bamias, Aristotelis ;

Castellano, Daniel ;

Khalil, Maged F. ;

Van der Heijden, Michiel Simon ;

Koshkin, Vadim S. ;

Pook, David William ;

Ozguroglu, Mustafa ;

Santiago, Linda ;

Saab, Rabih ;

Li, Pao-Chen ;

Tagliaferri, Margit Cecile ;

Lin, Wei ;

Tagliaferri, Mary Ann ;

Loriot, Yohann .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)

[28] NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies [J].

Choo, Joan R. ;

Jeraj, Santhiay Nathan ;

Sundar, Raghav ;

Yong, Wei Peng ;

Lee, Matilda ;

Huang, Yiqing ;

Asokumaran, Yugarajah ;

Chan, Gloria H. J. ;

Ngoi, Natalie Y. L. ;

Wong, Andrea L. A. ;

Soo, Ross A. ;

Chee, Cheng Ean ;

Lim, Joline S. J. ;

Goh, Boon Cher ;

Lee, Soo Chin ;

Tan, David S. P. .

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17

[29] NEXUS: A phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies [J].

Choo, J. ;

Jeraj, S. Nathan ;

Chan, G. ;

Sundar, R. ;

Yong, W. P. ;

Lee, M. ;

Ngoi, N. Y. L. ;

Wong, A. ;

Soo, R. A. ;

Chee, C. E. ;

Lim, J. ;

Goh, B-C. ;

Lee, S. C. ;

Tan, D. S. .

ANNALS OF ONCOLOGY, 2023, 34 :S1498-S1498

[30] A Phase I, Open-Label, Dose-Escalation Study of the OX40 Agonist Ivuxolimab in Patients with Locally Advanced or Metastatic Cancers [J].

Diab, Adi ;

Hamid, Omid ;

Thompson, John A. ;

Ros, Willeke ;

Eskens, Ferry A. L. M. ;

Doi, Toshihiko ;

Hu-Lieskovan, Siwen ;

Klempner, Samuel J. ;

Ganguly, Bishu ;

Fleener, Catherine ;

Wang, Xiao ;

Joh, Tenshang ;

Liao, Ken ;

Salek-Ardakani, Shahram ;

Taylor, Carrie Turich ;

Chou, Jeffrey ;

El-Khoueiry, Anthony B. .

CLINICAL CANCER RESEARCH, 2022, 28 (01) :71-83

← 1 2 3 4 5 →